Washington, DC 20006-5349
HELPLINE
Melissa Culligan, a member of the Mesothelioma Applied Research Foundation’s Board of Directors started her work on Saturday, December 3 at the 17th World Conference…
Results from studies using PDL1 inhibitors Today, at the World Conference on Lung Cancer 2016 (Mesothelioma Track), several investigators presented data for their immunotherapy studies.…
“Mesothelioma is known as a traditionally under-funded and under-studied cancer.” That’s the answer customarily given to patients, their families, and the public at large when…
This week, representatives of the Mesothelioma Applied Research Foundation are attending one of the largest medical conferences in the world: the World Conference on Lung…
We have some exciting news! We just learned that in honor of #GivingTuesday, Facebook and the Bill & Melinda Gates Foundation will contribute up to…
On Tuesday, November 1, the Meso Foundation held a Meet the Mesothelioma Experts session with Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center (MSKCC).…
BY JESSICA BLACKFORD-CLEETON A large number of warriors diagnosed with mesothelioma are over the age of 65, but there are several cases of diagnosis in…
by Marcia Schekel After 8 weeks of painful side effects from treatment, I looked at the CT with my oncologist to see the tumors growing…
On September 26, 2016, Meso Foundation volunteers and mesothelioma community members came out in force to raise awareness for Mesothelioma Awareness Day. We asked the…
On Friday, October 7, the Meso Foundation and the mesothelioma community will gather for the last time in 2016 for a one-day conference in Chicago,…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
